Edit |   |
---|---|
Antigenic Specificity | HLA-DRB, Human (Apolizumab biosimilar) |
Clone | Apolizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IP, FCM, FuncS, Neut, IF, ICC |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human HLA-DRB Recombinant Antibody. Apolizumab is a humanized monoclonal antibody intended for use in hematologic cancers. Development was abandoned in 2005 because of toxic effects and lack of efficacy in human patients. The observed dose limiting toxic effects were aseptic meningitis and hemolytic uremia. There are no current clinical trials into its use. |
Immunogen | n/a |
Other Names | Anti-HLA-DRB Recombinant Antibody, Research Grade Apolizumab, Anti-Human HLA-DRB Recombinant Antibody, Hu1D10, Apolizumab, 267227-08-7, Antibody Drug Analogues, Monoclonal Antibody, YR1018, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 267227-08-7 |
Catalog # | YR1018 |
Price | please inquire |
Order / More Info | HLA-DRB, Human (Apolizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |